To date, research on CDK13 function has focussed on its role in cancer; amplification of CDK13 has been seen in tumour cells (Kim et al., 2012) and CDK13 RNA over‐editing is a marker of poor prognosis in certain cancers (Dong et al., 2018). The gene discussed is CDK13; the disease is neoplasm.